With many significant scientific studies coming out on the therapeutic benefits of the compounds in cannabis there has been a growing interest in understanding how these compounds are produced in the plant. In 2011 these interests resulted in the formation of the company Medicinal Genomics, the first group to sequence the cannabis genome.
Kevin McKernan founder and CEO of Medicinal Genomics states that there are 84 compounds other than THC that could be used to treat a variety of ailments, however anti-drug laws make it difficult for scientists to breed and study the plant in most countries. That’s one of the reasons why he decided to publish the data for free on Amazon’s EC2, a public data cloud. McKernan hopes that their data will help scientists breed cannabis plants with lower THC content and higher amounts of the lesser known cannabinoids.
Check out the Medicinal Genomics website here: www.medicinalgenomics.com